Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set

Through 10 outstanding editions, Kelley & Firestein's Textbook of Rheumatology has provided authoritative, in-depth guidance in rheumatology with an ideal balance of basic science and clinical application. The 11th Edition of this classic text continues this tradition of excellence, while keeping you abreast of recent advances in genetics and the microbiome, new therapies such as biologics and biosimilars, and other rapid changes in the field. It provides comprehensive, global coverage of all aspects of diagnosis, screening, and treatment in both adults and children, in a user-friendly, full color reference. Covers everything from basic science, immunology, anatomy, and physiology to diagnostic tests, procedures, and specific disease processes-including key data on therapeutic outcomes to better inform clinical decision making. Includes new chapters on Innate Lymphoid Cells and Natural Killer Cells, Pathogenesis of Inflammasome Mediated Diseases, Bisphosphonates, Ultrasound Evaluation of the Musculoskeletal System, and Evaluation of Monoarticular and Polyarticular Arthritis. Features 1,200 high-quality illustrations, including superb line art, quick-reference tables, and full-color clinical photographs. Shares the knowledge and expertise of internationally renowned scientists and clinicians, including new editor Dr. Gary Koretzky, specialist in immunology and rheumatology. Demonstrates the complete musculoskeletal exam in online videos, including abnormal findings and the arthroscopic presentation of diseased joints. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Table of Contents:
VOLUME I Part 1: Structure and Function of Bone, Joints, and Connective Tissue 1. Biology of the Normal Joint, 1 Carla R. Scanzello and Steven R. Goldring 2. Synovium, 20 Douglas J. Veale and Gary S. Firestein 3. Cartilage and Chondrocytes, 34 Ali Mobasheri, Mary B. Goldring, and Richard F. Loeser 4. Biology, Physiology, and Morphology of Bone, 60 Aline Bozec, Anika Grüneboom, and Georg Schett 5. Muscle: Anatomy, Physiology, and Biochemistry, 67 Mark S. Miller, Edward P. Debold, and Michael J. Toth 6. Biomechanics, 80 Kenton R. Kaufman and KaiNan An 7. Regenerative Medicine and Tissue Engineering, 92 Frank P. Luyten, Cosimo De Bari, and Francesco Dell'Accio 8. Proteinases and Matrix Degradation, 109 Yoshifumi Itoh Part 2: Cells Involved in Autoimmune Diseases and Inflammation 9. Dendritic Cells, 132 Mansi Saxena, Nicolas Vabret, Luciana Ribeiro Muniz, and Nina Bhardwaj 10. Mononuclear Phagocytes, 149 Deborah R. Winter, Anna Montgomery, and Harris Perlman 11. Neutrophils, 161 Binita Shah, Nathalie Burg, and Michael H. Pillinger 12. T Lymphocytes, 182 Ralph C. Budd 13. B Cells, 199 Yong-Rui Zou, Christine Grimaldi, and Betty Diamond 14. Fibroblasts and Fibroblast-like Synoviocytes, 222 Christopher D. Buckley and Andrew Filer 15. Mast Cells, 241 Peter A. Nigrovic 16. Innate Lymphoid Cells and Natural Killer Cells, 254 Michael A. Paley and Wayne M. Yokoyama 17. Platelets and Megakaryocytes, 262 Eric Boilard and Peter A. Nigrovic Part 3: Effector Mechanisms in Autoimmunity and Inflammation 18. Principles of Signaling, 273 Abel Suarez-Fueyo, Vaishali R. Moulton, and George C. Tsokos 19. The Immunologic Repercussions of Cell Death, 286 Helen M. Beere and Douglas R. Green 20. Innate Immunity, 306 Gregoire Lauvau and Steven A. Porcelli 21. Adaptive Immunity, 320 Martha S. Jordan and Gary A. Koretzky 22. Autoimmunity and Tolerance, 337 Dwight H. Kono and Argyrios N. Theofilopoulos 23. The Microbiome in Health and Disease, 355 Rob Knight 24. Metabolic Regulation of Immunity, 368 Ruoning Wang, Tingting Wang, and Stephen Tait 25. Genetics of Rheumatic Diseases, 378 Stephen Eyre and Anne Barton 26. Epigenetics of Rheumatic Diseases, 393 Amr H. Sawalha and Matlock A. Jeffries 27. Complement System, 409 V. Michael Holers and Leendert A. Trouw 28. Prostaglandins, Leukotrienes, and Related Compounds, 420 Robert B. Zurier 29. Chemokines and Cellular Recruitment, 437 Gerard Graham 30. Angiogenesis, 445 Ursula Fearon, Zoltán Szekanecz, and Douglas J. Veale 31. Cytokines, 455 Iain B. McInnes 32. Experimental Models for Rheumatoid Arthritis, 467 Rikard Holmdahl 33. Neuronal Regulation of Pain and Inflammation, 480 Camilla I. Svensson and Linda S. Sorkin Part 4: Broad Issues in the Approach to Rheumatic Disease 34. Clinical Research Methods in Rheumatic Disease, 495 Jeffrey R. Curtis, Yvonne M. Golightly, and Kenneth G. Saag 35. Economic Impact of Arthritis and Rheumatic Conditions, 510 Louise B. Murphy 36. Assessment of Health Outcomes, 522 Dorcas E. Beaton, Maarten Boers, Peter Tugwell, and Lara Maxwell 37. Biomarkers in Rheumatology, 536 Michael J. Townsend, Saloumeh K. Fischer, and Andrew C. Chan 38. Occupational and Recreational Musculoskeletal Disorders, 551 Richard S. Panush 39. Cardiovascular Risk in Inflammatory Rheumatic Disease, 563 Cynthia S. Crowson, Sherine E. Gabriel, and Anne Grete Semb 40. Cancer Risk in Rheumatic Diseases, 579 Eric L. Matteson 41. Introduction to Physical Medicine and Rehabilitation, 592 Sara J. Cuccurullo, Jaclyn Joki, and Ofure Luke 42. Pregnancy and Rheumatic Diseases, 604 Lisa R. Sammaritano and Bonnie L. Bermas Part 5: Evaluation of Generalized and Localized Symptoms 43. History and Physical Examination of the Musculoskeletal System, 621 John M. Davis III, Kevin G. Moder, and Gene G. Hunder 44. Ultrasound in Rheumatology, 638 Eugene Y. Kissin, Paul J. DeMarco, and Amy C. Cannella 45. Evaluation of Monoarticular and Polyarticular Arthritis, 663 Ronald F. van Vollenhoven 46. Skin and Rheumatic Diseases, 678 David F. Fiorentino and Victoria P. Werth 47. The Eye and Rheumatic Diseases, 702 James T. Rosenbaum Part 6: Differential Diagnosis of Regional and Diffuse Musculoskeletal  Pain 48. Neck Pain, 711 Jennifer Kosty, Rani Nasser, Raul A. Vasquez, Cyrus C. Wong, and Joseph S. Cheng 49. Shoulder Pain, 727 Scott David Martin and Thomas S. Thornhill 50. Low Back Pain, 753 Rajiv Dixit 51. Hip and Knee Pain, 776 James I. Huddleston, III, and Stuart Goodman 52. Foot and Ankle Pain, 792 Christopher P. Chiodo, Mark D. Price, and Adam P. Sangeorzan 53. Hand and Wrist Pain, 800 Kenneth W. Donohue, Felicity G. Fishman, and Carrie R. Swigart 54. Temporomandibular Joint Pain, 813 Daniel M. Laskin 55. Fibromyalgia, 825 Leslie J. Crofford Part 7: Diagnostic Tests and Procedures in Rheumatic Diseases 56. Synovial Fluid Analyses, Synovial Biopsy, and Synovial Pathology, 841 Hani S. El-Gabalawy and Stacy Tanner 57. Arthrocentesis and Injection of Joints and Soft Tissues, 859 Ahmed S. Zayat, Andrea di Matteo, and Richard J. Wakefield 58. Anti-nuclear Antibodies, 875 Stanford L. Peng and Joseph E. Craft 59. Autoantibodies in Rheumatoid Arthritis, 890 Erika Darrah, Antony Rosen, and Felipe Andrade 60. Acute Phase Reactants, 907 Rebecca Haberman, Cesar E. Fors Nieves, Bruce N. Cronstein, and Amit Saxena 61.Imaging in Rheumatic  Diseases,  920 Mikkel Østergaard, Ho Jen, Jacob L. Jaremko, and Robert G.W. Lambert Part 8:  Pharmacology of Anti-rheumatic Drugs 62. Therapeutic Targeting of Prostanoids, 965 Leslie J. Crofford 63. Glucocorticoid Therapy, 985 Marlies C. van der Goes and Johannes W.G. Jacobs 64. Traditional DMARDs: Methotrexate, Lefl, Sulfasalazine, Hydroxychloroquine, and Combination Therapies, 1007 Amy C. Cannella and James R. O'Dell 65. Immunosuppressive Drugs, 1031 Jacob M. van Laar 66. Anti-cytokine Therapies,   1046 Katharine McCarthy, Arthur Kavanaugh, and Christopher T. Ritchlin 67. Cell-Targeted Biologics and Emerging Targets: Rituximab, Abatacept, and Other Biologics, 1068 Peter C. Taylor 68. Intra-cellular Targeting Agents in Rheumatic Disease, 1091 Virginia Reddy and Stanley Cohen 69. Urate-Lowering Therapy, 1111 Ted R. Mikuls 70. Bisphosphonates, 1125 Arthur C. Santora II and Kenneth G. Saag 71. Analgesic Agents in Rheumatic Disease, 1135 Gregory R. Polston and Mark S. Wallace 72. Nutrition and Rheumatic Diseases, 1156 Lisa K. Stamp and Leslie G. Cleland 73. Evaluation and Management of Early Undifferentiated Arthritis, 1173 Karim Raza VOLUME II Part 9:  Rheumatoid Arthritis 74. Etiology of Rheumatoid Arthritis, 1181 Gary S. Firestein 75. Pathogenesis of Rheumatoid Arthritis, 1200 Gary S. Firestein 76. Clinical Features of Rheumatoid Arthritis, 1236 Bryant R. England and Ted R. Mikuls 77. Treatment of Rheumatoid Arthritis, 1258 James R. O'Dell 78. Sjögren's Syndrome, 1284 E. William St. Clair and David L. Leverenz Part 10: Spondyloarthritis 79. Etiology and Pathogenesis of Spondyloarthritis, 1307 Keith A. Sikora and Robert A. Colbert 80. Ankylosing Spondylitis and Other Forms of Axial Spondyloarthritis,  1319 Sjef van der Linden, Matthew Brown, Lianne S. Gensler, Tony Kenna, Walter P. Maksymowych, and William J. Taylor 81. Reactive Arthritis, 1344 John D. Carter and Alan P. Hudson 82. Psoriatic Arthritis, 1359 Oliver FitzGerald and Conor Magee 83. Inflammatory Bowel Disease-Associated Arthritis and Other Enteropathic Arthropathies, 1381 Richard Zamore, Meenakshi Bewtra, and Alexis Ogdie Part 11: Systemic Lupus Erythematosus and Related Syndromes 84. Etiology and Pathogenesis of Systemic Lupus Erythematosus, 1396 Mary K. Crow 85. Clinical Features of Systemic Lupus Erythematosus, 1413 Maria Dall'Era and David Wofsy 86. Treatment of Systemic Lupus Erythematosus, 1437 Antonis Fanouriakis, George Bertsias, and Dimitrios T. Boumpas 87. Antiphospholipid Syndrome, 1460 Medha Barbhaiya, Jane E. Salmon, and Doruk Erkan Part 12: Systemic Sclerosis, Inflammatory Myopathies, and Overlap Syndromes 88. Etiology and Pathogenesis of Systemic Sclerosis, 1473 John Varga 89. Clinical Features and Treatment of Scleroderma, 1499 Fredrick M. Wigley and Francesco Boin 90. Inflammatory Diseases of Muscle and Other Myopathies, 1539 Kanneboyina Nagaraju, Rohit Aggarwal, and Ingrid E. Lundberg 91. Overlap Syndromes, 1569 Jonathan Graf Part 13:  Vasculitis 92. Classification and Epidemiology of Systemic Vasculitis, 1584 Rennie L. Rhee and Peter A. Merkel 93. Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu's Arteritis, 1595 David B. Hellmann 94. Anti-neutrophil Cytoplasmic Antibody- Associated Vasculitis, 1617 Sharon A. Chung and Paul A. Monach 95. Polyarteritis Nodosa and Related Disorders, 1634 Raashid Luqmani and Abid Awisat 96. Immune Complex-Mediated Small Vessel Vasculitis, 1649 John H. Stone 97. Primary Angiitis of the Central Nervous System, 1659 Rula A. Hajj-Ali and Carol A. Langford 98. Behçet's Disease, 1666 Christine S. Ahn, Lindsay C. Strowd, and Joseph L. Jorizzo Part 14: Crystal-Induced and Inflammasome- Mediated Inflammation 99. Pathogenesis of Inflammasome-Mediated Diseases, 1676 Hal M. Hoffman and Lori Broderick 100. Etiology and Pathogenesis of Hyperuricemia and Gout, 1687 Robert T. Keenan, Michael Toprover, and Michael H. Pillinger 101. Clinical Features and Treatment of Gout, 1710 Nicola Dalbeth 102. Calcium Crystal Disease: Calcium Pyrophosphate Dihydrate and Basic Calcium Phosphate, 1732 Robert Terkeltaub 103. Familial Autoinflammatory Syndromes, 1752 Catharina M. Mulders-Manders, Anna Simon, and Jos W.M. van der Meer Part 15: Cartilage, Bone, and Heritable Connective Tissue Disorders 104. Pathogenesis of Osteoarthritis, 1770 Paul E. Di Cesare, Dominik R. Haudenschild, Steven B. Abramson, and Jonathan Samuels 105. Clinical Features of Osteoarthritis, 1789 Amanda E. Nelson 106. Treatment of Osteoarthritis, 1803 Devyani Misra, Deepak Kumar, and Tuhina Neogi 107. Metabolic Bone Disease, 1819 Nancy E. Lane 108. Proliferative Bone Diseases, 1839 Reuven Mader 109. Osteonecrosis, 1852 Christopher Chang, Adam Greenspan, and M. Eric Gershwin 110. Relapsing Polychondritis, 1876 Gaye Cunnane 111. Heritable Diseases of Connective Tissue, 1886 Deborah Krakow Part 16: Rheumatic Diseases of Childhood 112. Etiology and Pathogenesis of Juvenile Idiopathic Arthritis, 1905 Edward M. Behrens 113. Clinical Features and Treatment of Juvenile Idiopathic Arthritis, 1911 Joyce J. Hsu, Tzielan C. Lee, and Christy I. Sandborg 114. Childhood-Onset Systemic Lupus Erythematosus, Drug-Induced Lupus in Children, and Neonatal Lupus, 1931 Stacy P. Ardoin and Fatima Barbar-Smiley 115.Juvenile Dermatomyositis, Scleroderma, Vasculitis, and Autoimmune Brain Disease,  1942 Angela B. Robinson, Jeffrey Dvergsten, Kathryn S. Torok, Heather Van Mater, William Gallentine, and Ann M. Reed Part 17: Infection and Arthritis 116. Bacterial Arthritis, 1979 Paul P. Cook and Dawd S. Siraj 117. Lyme Disease, 1994 Linda K. Bockenstedt 118. Mycobacterial Infections of Bones and Joints, 2009 Eric M. Ruderman and John P. Flaherty 119. Fungal Infections of Bones and Joints, 2022 Eric M. Ruderman and John P. Flaherty 120. Rheumatic Manifestations of HIV Infection, 2033 Jonathan Dau and John D. Reveille 121. Viral Arthritis, 2048 Philippe Gasque and Xavier Guillot 122. Rheumatic Fever and Post-streptococcal Arthritis, 2061 Luiza Guilherme, Pedro Ming Azevedo, and Jorge Kalil Part 18: Arthritis Accompanying Systemic Disease 123. Amyloidosis, 2077 Helen J. Lachmann and Faye A. Sharpley 124. Sarcoidosis, 2088 Peter Korsten, Nadera J. Sweiss, and Robert P. Baughman 125. Hemochromatosis, 2105 Gaye Cunnane 126. Hemophilic Arthropathy, 2115 Astrid E. Pulles, Lize F. D. van Vulpen, and Floris P.J.G. Lafeber 127. Rheumatic Manifestations of Hemoglobinopathies,  2127 Carlos J. Lozada and Elaine C. Tozman 128. IgG4-Related Disease, 2135 John H. Stone and Shiv Pillai 129. Arthritis Accompanying Endocrine and Metabolic Disorders, 2149 Sebastian E. Sattui and Joseph A. Markenson 130. Rheumatic  Paraneoplastic  Syndromes-Links Between Malignancy and Autoimmunity, 2161 Bernhard Manger and Georg Schett 131. Tumors and Tumor-like Lesions of Joints and Related Structures, 2167 Darcy A. Kerr and Andrew E. Rosenberg 132. Autoimmune Complications of Immune Checkpoint Inhibitors for Cancer, 2189 Laura C. Cappelli, Clifton O. Bingham III, and Ami A. Shah Index, I-1  

About the Author :
Gary Firestein, MD, is a board-certified rheumatologist who diagnoses and treats patients with autoimmune conditions as well as diseases of the joints, muscles and bones. A professor at UC San Diego School of Medicine, Dr. Firestein is distinguished for his research and serves as director of the Altman Clinical and Translational Research Institute and the senior associate vice chancellor for health sciences. Dr. Firestein's research interest focuses on the pathogenesis and treatment of rheumatoid arthritis. Dr. Firestein is the recipient of many awards and honors, including the Arthritis Foundation's Jane Wyman Humanitarian Award in 2010 for his contributions to rheumatology; the Arthritis Foundation Lee C. Howley Sr. Prize for Arthritis Research; and the American College of Rheumatology Distinguished Investigator Award. He has been elected to the American Society for Clinical Investigation and the Association of American Physicians. He has served as an editor for the Textbook of Rheumatology for since the 7th edition (2004). Iain McInnes is Director of the Institute of Infection, Immunity and Inflammation at the University of Glasgow, UK. He has extensive experience in leading multicenter programs nationally and internationally. He is Director of the Scottish MRC Clinical Pharmacology and Pathology Clinical PhD Training Program, Chief Investigator for the Scottish Early RA Cohort (SERA) and the related SMS-IC biomarker discovery program (PROMISERA), and chief investigator of numerous global phase II and III clinical trials of novel immune therapies. He has served as member or chair of numerous national grant-funding panels and as chair of several European League Against Rheumatism (EULAR) scientific committees - he is now Treasurer and President Elect of EULAR serving on its Steering Committee. He is formerly Chairman of the Foundation for European Rheumatology Research (Foreum) Scientific Committee and leads the EULAR-supported European Roadmap Program that is defining the research agenda for rheumatology for the next decade. James R. O'Dell, MD is the Stokes Shackleford Professor of Internal Medicine, Vice-Chairman of Internal Medicine and Chief of the Division of Rheumatology at the University of Nebraska Medical Center (UNMC) in Omaha. Dr. O'Dell founded and has directed the Rheumatoid Arthritis Investigational Network (RAIN) for the last 25 years. Dr. O'Dell is the PI of the large multinational RA research study based at the VA through their cooperative studies program. Dr. O'Dell has published extensively, mostly in the area of rheumatoid arthritis. He has presented frequently at national and international meetings and has more than 100 published articles in top-level rheumatology journals. He has served on numerous American College of Rheumatology (ACR) committees over the last 20 years, including time on both the ACR and REF BOD, as well as a two-year term as President of the Research and Education Foundation of the ACR and was President of the College (2011-2012). Additionally, he is Editor-in-Chief of Up To Date for Rheumatology. Gary Koretzky, MD, PhD is Professor of Medicine at Weill Cornell Graduate School. Dr. Koretzky's research aims to better understand the signal transduction events that occur following engagement of the T cell antigen receptor. He has been continuously funded by the National Institutes of Health since establishing his independent research group, as the laboratory has expanded its interests to study more globally the molecular events important for immune cell development, differentiation and function. Dr. Koretzky has published more than 200 research articles. He is a past President of the American Society of Clinical Investigation (2000) and Councilor of the Association of American Physicians (2008-2012), is a Fellow of the American Association for the Advancement of Science (2004), a member of the Institute of Medicine of the National Academies (2008), a Fellow of the American Academy of Arts & Sciences (2012) and serves as the Editor-in-Chief of Immunological Reviews (2002-present).

Review :
Doody's Core Titles® 2021 Essential Purchase